SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver

Acta Radiologica

Volumn 40, Issue 6, 1999, Pages 628-635

  Müller, Ralf Dietrich ^a   Vogel, K ^a   Neumann, K ^a   Hirche, H ^b   Barkhausen, J ^a   Stoblen F ^a   Henrich, H ^a   Langer, R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Contrast enhancement, iron particles; Liver neoplasms, MR imaging

Indexed keywords

CONTRAST MEDIUM; IRON; OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOGRAPHY;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OXIDES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033219901     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859909175600     Document Type: Article

References (36)

1. BARON R. L.: Understanding and optimizing use of contrast material for CT of the liver. AJR 163 (1994), 323.
2. BELLIN M. F., ZAIM S., AUBERTON E. et al.: Liver metastases. Safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 193 (1994), 657.
3. BLAKEBOROUGH A., WARD J., WILSON D. et al.: Hepatic lesion detection at MR imaging. A comparative study with four sequences. Radiology 203 (1997), 759.
4. CHOI B. I., HAN J. K., CHO J. M. et al.: Characterization of focal hepatic tumors (value of two-phase computed tomography). Cancer 12 (1995), 2434.
5. EDELMANN R. R., SIEGEL J. B., SINGER A., DUPUIS K. & LONGMAID H. E.: Dynamic MR imaging of the liver with Gd-DTPA. Initial clinical results. AJR 153 (1989), 1213.
6. FISHBEIN M., LONG F. & SMITH M.: Fast gradient echo MR imaging of the liver enhanced with superparamagnetic iron oxide. Magn. Reson. Imaging 15 (1997), 651.
7. FREDERICK M. G., PAULSON E. K. & NELSON R. C.: Helical CT for detecting focal liver lesions in patients with breast carcinoma. Comparison of noncontrast phase, hepatic arterial phase and portal venous phase. J. Comput. Assist. Tomogr. 21 (1997), 229.
8. FRETZ C. J., STARK D. D., METZ C. E. et al.: Detection of hepatic metastases. Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR 155 (1990), 763.
9. GAA J., FISCHER H., LAUB G. & GEORGI M.: Breath-hold MR imaging of focal liver lesions. Comparison of fast and ultrafast techniques. Eur. Radiol. 6 (1996), 838.
10. GRANGIER C., TOURNIAIRE J., MENTHA G. et al.: Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J. Comput. Assist. Tomogr. 18 (1994), 888.
11. HAGSPIEL K. D., NEIDL K. F. W., EICHENBERGER A. C., WEDER W. & MARINCEK B.: Detection of liver metastases. Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196 (1995), 471.
12. HALAVAARA J., LAMMINEN A. E., BONDESSTAM S., STANDERTSKJÖLD-NORDENSTAM C. G. & HAMBERG L. M.: Detection of focal liver lesions with superparamagnetic iron oxide. Value of STIR and SE imaging. J. Comput. Assist. Tomogr. 18 (1994), 897.
13. HAMM B., REICHEL M., VOGL T., TAUPITZ M. & WOLF K. G.: Superparamagnetische Eisenpartikel. RÖFO 160 (1994), 52.
14. HOLLETT M. D., JEFFREY R. B., NINO-MURCIA M., JORGENSEN M. J. & HARRIS D. P.: Dual-phase helical CT of the liver. Value of arterial phase scans in the detection of small (< 1.5 cm) malignant hepatic neoplasms. AJR 164 (1995), 879.
15. HRUBY W. & STELLAMOR K.: Kontrastmittelverhalten von Lebertumoren in CT-Korrelation zwischen Pharmakokinetik und feingeweblichem Bau. Röntgenblätter 41 (1988), 133.
16. JUNG G., KRAHE T, KUGEL H. et al.: Prospective comparison of fast SE and GRASE sequences and echo planar imaging with conventional SE sequences in the detection of focal liver lesions at 1.0 T. J. Comput. Assist. Tomogr. 21 (1997), 341.
17. MARCHAL G., VAN HECKE P., DEMAEREL P. et al.: Detection of liver metastases with superparamagnetic iron oxide in 15 patients. Results of MR imaging at 1.5 T. AJR 152 (1989), 771.
18. OESTMANN J. W. & GALANSKI M.: Methodik zum Vergleich der diagnostischen Leistung bildgebender Verfahren. RÖFO 151 (1989), 89.
19. OLIVER J. H., BARON R. L., FEDERLE M. P. & ROCKETTE H. E.: Detecting hepatocellular carcinoma. Value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR 167 (1996), 71.
20. OUDKERK M., VAN DEN HEUVEL A. G., WIELPOLSKI P. A., SCHMITZ P. I., BOREL-RINKES I. H. & WIGGERS T.: Hepatic lesions. Detction with ferrumoxide-enhanced T1-weighted MR imaging. Radiology 203 (1997), 449.
21. Ros P. R., FEENY P. C., HARMS S. E. et al.: Hepatic MR imaging with ferrumoxides. A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196 (1995), 481.
22. SACHS L. (also editor): Varianzanalytische Methoden. In: Angewandte Statistik, p. 612. Springer-Verlag, Berlin 1992.
23. SAJNI S., STARK D. D., HAHN P. F., WITTENBERG J., BRADY T. J. & FERRUCI J. T.: Ferrite particles. A superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 162 (1987), 211.
24. SAINI S., STARK D. D., HAHN P. F. et al.: Ferrite particles. A superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology 162 (1987), 217.
25. SCHWARTZ L. H., SELTZER S. E., ADAMS D. F. et al.: Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences. Invest. Radiol. 29 (1994), 21.
26. STARK D. D., WEISSLEDER R., ELIZANDO G. et al.: Superparamagnetic iron oxide. Clinical application as a contrast agent for MR imaging of the liver. Radiology 168 (1988), 297.
27. SUTO Y., KODAMA F., KAMBA M. & OHTA Y.: Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma. Acta Radiol. 36 (1995), 102.
28. TAYLOR P. M., HAWNAUR J. M. & HUTCHINSON C. E.: Superparamagnetic iron oxide imaging of focal liver disease. Clin. Radiol. 50 (1995), 215.
29. URHAHN R., ADAM G., BUSCH N., CHEN J. H., EURINGER W. & GÜNTHER R. W.: Superparamagnetische Eisenoxidpartikel. Welchen Stellenwert hat der T1-Effekt für die MR-Diagnostik fokaler Leberläsionen? RÖFO 165 (1996), 364.
30. VAN-GANSBEKE D., METENS T. M., MATOS C. et al.: Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images. Implications for tumor characterization. J. Magn. Reson. Imaging 7 (1997) 482.
31. VAN HOE L., BOSMANS H., AERTS P. et al.: Focal liver lesions. Fast T2-weighted MR imaging with half-Fourier rapid acquisition with relaxation enhancement. Radiology 201 (1996), 817.
32. VOGL T. J., HAMMERSTINGL R., PEGIOS W. et al.: Wertigkeit des leberspezifischen superparamagnetischen Kontrastmittels AMI-25 für die Detektion und Differentialdiagnose lebereigener Tumoren versus Metastasen. RÖFO 160 (1994), 319.
33. WEISSLEDER R., STARK D. D., ENGELSTADT D. L. et al.: Superparamagnetic iron oxide. Pharmacokinetics and toxicity. AJR 152 (1989), 167.
34. WINTER T. C., FREENY P. C., NGHIEM H. V. et al.: MR imaging with superparamagnetic iron oxide efficacy in the detection of focal hepatic lesions. AJR 161 (1993), 1191.
35. YAMAMOTO H., YAMASHITA Y., YOSHIMATSU S. et al.: Hepatocellular carcinoma in cirrhotic livers. Detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 195 (1995), 106.
36. ZWICKER C., LANGER M., ASTINET F., LANGER R., ULRICH V. & FELIX R.: Differenzierung maligner Lebertumoren mit schneller dynamischer CT. RÖFO 152 (1990), 293.